Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:00 AM
Ignite Modification Date:
2025-12-25 @ 9:58 PM
NCT ID:
NCT04208958
Group ID:
EG000
Title:
VE800 combination treatment with nivolumab (Melanoma)
Description:
Subjects received 5 days of oral vancomycin, followed by daily VE800 in combination with nivolumab every 4 weeks.
VE800: VE800 is a PO LBP consisting of 11 distinct nonpathogenic, nontoxigenic, commensal bacterial strains manufactured under GMP conditions. These strains were selected for their ability to induce an immune response.
Nivolumab: Nivolumab is an approved medication that blocks antibodies for certain types of cancer.
Vancomycin Oral Capsule: Vancomycin is an antibiotic used to treat or prevent infection.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
21
Other Number Affected:
13
Other Number At Risk:
21
Study:
NCT04208958
Results Section:
NCT04208958
Adverse Events Module:
NCT04208958